Ona Therapeutics to develop ADC with WuXi’s payload-linker platform
The deal grants Ona Therapeutics rights to develop an ADC targeting a single undisclosed target.
Drug Development
Roche agrees to $1bn deal with Dualitas for bispecific antibody research
Cellares and GenomeFrontier to assess automated GF-CART01 production
Viatris’ Wakix receives Japanese approval to treat OSAS and narcolepsy
Gilead and PAHO agree to expedite lenacapavir access for HIV prevention
Eli Lilly and QurCan sign genetic medicine deal
Cheplapharm to take over 20 medicines and three sites from Sanofi
FDA reduces monitoring time for Amgen’s Imdelltra infusions
